IC
YARW

Ikarian Capital’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Ikarian Capital’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158K Hold
5,298
– – 0.01% 143
2025
Q4 		$154K Sell
5,298
-502
-9% -$10.1K 0.01% 157
2025
Q3 		$97.1K Hold
5,800
– – 0.01% 163
2025
Q2 		$479K Buy
+5,800
New +$377K 0.09% 92

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ikarian Capital's YARW Position: Q1 2026 in Review

Ikarian Capital held its Yarrow Bioscience, Inc. Common Stock (YARW) position steady in Q1 2026 at 5,298 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #143.

Ikarian Capital first reported a position in YARW in Q2 2025 and has held it in 4 quarters since. The position peaked at $479K in Q2 2025. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Ikarian Capital held 5,298 shares of Yarrow Bioscience, Inc. Common Stock worth $158K as of Q1 2026.
  • Ikarian Capital left its Yarrow Bioscience, Inc. Common Stock share count unchanged in Q1 2026.
  • Yarrow Bioscience, Inc. Common Stock made up 0.01% of Ikarian Capital's portfolio in Q1 2026, its #143 holding.
  • Ikarian Capital first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
  • Ikarian Capital's Yarrow Bioscience, Inc. Common Stock position peaked at $479K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.